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Transgenic technologies enable the manipulation and observation of circuits controlling
behavior by permitting expression of genetically encoded reporter genes in neurons.
Frequently though, neuronal expression is accompanied by transgene expression in
non-neuronal tissues, which may preclude key experimental manipulations, including
assessment of the contribution of neurons to behavior by ablation. To better restrict
transgene expression to the nervous system in zebrafish larvae, we have used DNA
sequences derived from the neuron-restrictive silencing element (NRSE). We find that
one such sequence, REx2, when used in conjunction with several basal promoters,
robustly suppresses transgene expression in non-neuronal tissues. Both in transient
transgenic experiments and in stable enhancer trap lines, suppression is achieved without
compromising expression within the nervous system. Furthermore, in REx2 enhancer
trap lines non-neuronal expression can be de-repressed by knocking down expression
of the NRSE binding protein RE1-silencing transcription factor (Rest). In one line, we
show that the resulting pattern of reporter gene expression coincides with that of
the adjacent endogenous gene, hapln3. We demonstrate that three common basal
promoters are susceptible to the effects of the REx2 element, suggesting that this
method may be useful for confining expression frommany other promoters to the nervous
system. This technique enables neural specific targeting of reporter genes and thus will
facilitate the use of transgenic methods to manipulate circuit function in freely behaving
larvae.
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INTRODUCTION
Random mutagenesis screens have provided profound insights
into neuronal circuits that control behavior in simple inverte-
brate species (Benzer, 1971; Brenner, 1974). Such screens have
proven to be a less efficient tool for investigating the neuronal
basis of behavior in vertebrates, as mutations that alter behav-
ior often disrupt brain architecture so broadly that it is difficult
to link behavioral phenotypes to specific structural deficits, or
result in changes to circuit function so subtle that they are difficult
to recognize. An appealing alternative is to generate transgenic
lines with unique patterns of labeled neurons by exploiting cis
regulatory DNA elements involved in the regulation of gene
expression (Pfeiffer et al., 2008). Using a large collection of such
lines to drive the expression of transgenes whose products inter-
fere with neuronal function, a “circuit breaking” screen can be
performed, testing for behavioral deficits which result from inac-
tivation of the targeted neurons (Asakawa et al., 2008). Such
an approach retains the unbiased nature of mutagenesis screen-
ing but disrupts brain function at a level suitable for circuit
analysis.
Several methods have been developed for conditional inacti-
vation of neurons. Conditional silencing technologies have the
advantage of reversibility (Kitamoto, 2001; Tan et al., 2006; Zhang
et al., 2007; Chow et al., 2010), however, proving that neurons
are silenced requires electrophysiological characterization, mak-
ing this technology best suited for testing specific hypotheses
rather than for conducting behavioral screens. In contrast, neu-
ronal ablation using genetically encoded toxins can be quickly
monitored using co-expressed fluorescent reporters or histolog-
ical techniques (Nirenberg and Meister, 1997; Chu et al., 2008;
Hamm et al., 2009; Del Bene et al., 2010; Lee et al., 2010).
It has recently been shown that the bacterial gene nfsB, which
encodes the enzyme nitroreductase (NTR), can be used for con-
ditional ablation of cells including neurons in zebrafish. NTR
converts the cell-permeable substrate metronidazole into a cell-
impermeable cytotoxin preventing damage to neighboring cells
(Curado et al., 2007; Pisharath et al., 2007; Zhao et al., 2009;
Fernandes et al., 2012). Together with advances in transgenic
technology that allow for rapidly generating libraries of zebrafish
enhancer trap lines (Kawakami et al., 2000; Kawakami, 2004;
Emelyanov et al., 2006; Urasaki et al., 2006; Koga et al., 2008),
this opens the possibility of screening for neuronal function by
using these lines to drive expression of a temporally controlled
cell death gene.
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Enhancer trap screens have generated numerous stable trans-
genic lines with reporter genes expressed in restricted neuronal
patterns (Parinov et al., 2004; Ellingsen et al., 2005; Davison et al.,
2007; Scott et al., 2007; Asakawa et al., 2008; Distel et al., 2009;
Scott and Baier, 2009), but most such lines express transgenes
not only in the brain, but also in non-neuronal tissues including
heart, muscle, skin, and notochord (Scott et al., 2007). Ablation
of these structures either kills or produces morphological abnor-
malities in larvae which preclude behavioral testing. To surmount
this difficulty we sought to develop a method for generating
transgenic lines that would permit selective ablation of neuronal
structures.
The RE1-silencing transcription factor (Rest) recognizes a
21 bp DNA motif, the neuron-restrictive silencing element
(NRSE) and represses gene expression by recruiting a complex of
silencing factors (Mori et al., 1990; Kraner et al., 1992; Mori et al.,
1992; Andres et al., 1999; Huang et al., 1999; Ding et al., 2009).
The NRSE is found mainly in the regulatory regions of neuronal
genes, whereas Rest is primarily expressed in non-neuronal tissues
and neural progenitor cells, acting to silence premature and non-
specific neuronal gene expression (Chong et al., 1995; Schoenherr
and Anderson, 1995; Chen et al., 1998). NRSE sites are abun-
dant in vertebrates including zebrafish (Mortazavi et al., 2006)
and the zebrafish rest gene is expressed in a pattern consistent
with a role in silencing neuronal gene expression in immature
neuronal progenitor cells and outside the nervous system (Gates
et al., 2010).
We hypothesized that adding a NRSE to the transgene pro-
moter would suppress reporter expression in non-neuronal
tissues. Here we define a short DNA sequence based on a com-
bination of two NRSE motifs that can be easily incorporated into
existing enhancer trap vectors that improves the recovery of brain
specific enhancer trap lines 5-fold in 4 days post fertilization (dpf)
larvae. This opens the possibility of combining enhancer trapping




Tuebingen long fin strain zebrafish were used in this study.
Embryos were raised in E3 medium supplemented with 1.5mM
HEPES pH 7.3 (E3h) at 28◦C on a 14 h:10 h light:dark cycle
with medium changes every 2 days. Transgenic lines were
generated using Tol2 mediated transgenesis (Kawakami, 2004).
For transient transgenic experiments in Tg(UAS:Kaede)s1999t
embryos (Davison et al., 2007), we used the offspring of
homozygous transgenic fish. To identify homozygotes, we first
used linker-mediated PCR (see below) to locate the trans-
gene insertion site to chr5:32007986 (zv9). Genomic PCR
using primers GenKL 5-tgcgtagaaaatagctttgga and TraKR 5-
cttggaggcctaagcttgat amplify a 247 bp band from the trans-
gene containing allele, and primers GenKL and GenKR 5-
ccatttgttggtttgcattt amplify a 374 bp band from the wildtype
genomic allele. To generate low frequency mosaic reporter
expression (Downes et al., 2002), we injected 5 pg linearized
plasmid (35 pg for REx4-SCP1:Gal4 which strongly suppressed
expression) without transposase and raised embryos in 0.003%
phenylthiourea (Sigma) until 48 hpf. The amount of plasmid
was calibrated to produce only a few cells expressing the
reporter per embryo, with around 50% of embryos showing
no expression in the tissues scored. Embryos were inspected
for the presence of any cells expressing Kaede in brain,
heart, muscle, notochord, and skin. All in vivo experimen-
tal protocols were approved by the local animal care and use
committee.
PLASMID CONSTRUCTION
To make Gal4 reporter constructs, Gal4ff (a variant of Gal4
engineered to reduce toxicity) (Asakawa et al., 2008) was sub-
cloned from pT2KhspGFF into plasmid pBT2 which contains
Tol2 arms (gift of Shannon Fisher), with the sequence modified
to create a multiple cloning site and a canonical GCCACC Kozak
sequence before the ATG (Distel et al., 2009), creating plasmid
pT2MCSkG4FF. To make cFos:kGal4ff, we inserted an oligonu-
cleotide encoding the basal cFos promoter (5-CCAGTGACGTAG
GAAGTCCATCCATTCACAGCGCTTCTATAAAGGCGCCAGCT
GAGGCGCCTACTACTCCAACCGCGACTGCAGCGAGCAACT)
(Dorsky et al., 2002; Fisher et al., 2006; Scott and Baier, 2009)
between SalI and NcoI sites in pT2MCSkG4FF. For SCP1:kGal4ff,
we inserted an oligonucleotide encoding the super core promoter
1 (5-GTACTTATATAAGGGGGTGGGGGCGCGTTCGTCCTCA
GTCGCGATCGAACACTCGAGCCGAGCAGACGTGCCTACGG
ACCG) between SalI and BamHI sites in pT2MCSkG4FF. The
cFos:kGal4ff and SCP1:kGal4ff vectors were subsequently each
linearized upstream of the basal promoter with EcoRV, and
ligated to an oligonucleotide containing the REx2 element
(REx2, NRSE elements underlined: 5-TCAGCACCACGGACAG
GAAGATTTACCATACCGACAATTACTATCAGCACCGCGGAC
AG). The 16 bp NRSE elements used were computationally iden-
tified as the core of common Fugu NRSE sequences (Bruce et al.,
2004). For pilot experiments with SCP1:kGal4ff, we also tested
a single NRSE element (REx1: 5-TCAGCACCACGGACAG),
two different NRSE elements with a 27 bp spacer (REx2),
or tandem copies of the REx2 element (REx4). For testing
the REx2 with the heat shock promoter (Halloran et al.,
2000), we inserted an oligonucleotide containing the REx2
sequence into the ApaI site of pT2KhspGFF (Asakawa et al.,
2008).
In situ HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY
Larvae were fixed in 4% paraformaldehyde. Standard colorimet-
ric whole-mount in situ hybridization (WISH) and immuno-
histochemistry was performed as described in Bergeron et al.
(2008). For WISH, a hapln3 fragment was amplified by
RTPCR from 24 hpf embryonic RNA (primers 5-GATGGT
CTGGAGGACGAGAG and 5-TGTCCCATTCCACAGAAGTG)
and cloned into pGEM-T Easy (Promega, Madison, WI).
Antibodies were anti-Kaede (PM012, 1:200, MBL International,
Woburn, MA) and anti-elavl (16A11, 1:500, Invitrogen),
detected by AlexaFluor488 and AlexaFluor633-conjugated sec-
ondary antibodies (1:800 and 1:500 respectively, Invitrogen,
Carlsbad, CA) and counterstained with Hoechst 33342 (1:200,
H1399, Invitrogen). Confocal z-stacks were recorded using a
Leica TCS5 SPII laser scanning confocal microscope. ImageJ was
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used to create z-projections and merged images (Schneider et al.,
2012).
TRANSGENE MAPPING
Linker-mediated PCR was performed using NlaIII, BfaI and
DpnII linkers (Dupuy et al., 2005; Davison et al., 2007), with PCR
products resolved by gel electrophoresis and directly sequenced.
For Et(REx2-cFos:Gal4ff)y237, the integration was confirmed
using PCR on genomic DNA from single embryos, primers
x382GL 5-ttttggcttccaccttgaac, x382GR 5-tccagctcgcgaacaataat
and x382TL 5-caagaatctctagttttctttcttgc yielding 143 bp for the
wildtype genomic band and 219 bp in transgenic fish. In an out-
cross of Et(REx2-cFos:Gal4ff)y237; Tg(UAS:Kaede)s1999t, both
bands were present in all Kaede positive embryos (n = 25), con-
firming the integration site.
MORPHOLINOS
For rest knockdown experiments we used a previously charac-
terized splice-blocking morpholino (Gene Tools, Philomath, OR)
against the intron-exon boundary of zebrafish rest exon 3 (Gates
et al., 2010), injected at 5 ng per embryo using standard tech-
niques (Eisen and Smith, 2008), with controls receiving 5 ng of
the Gene Tools standard control morpholino. The control and
rest morpholinos were injected into a similar number of embryos
from each batch, so that the effect of rest knockdown could be
quantified using sibling controls.
BIOINFORMATICS
Analysis of NRSE sequences was performed on zebrafish genome
assembly Zv9, downloaded from NCBI, with code written in
IDL. For analyzing the distance of each NRSE to neighboring
sites, a less stringent NRSE definition was used allowing 2 mis-
matches to the consensus because there is evidence that multiple
weak sites may contribute to silencing (Mortazavi et al., 2006).
Sequence logo was generated using Web logo (Crooks et al.,
2004).
STATISTICAL ANALYSIS
During the enhancer trap screens, we retained the first 50 F1 lines
showing any Kaede reporter expression regardless of location or
perceived “quality.” As some lines were lost before they could
be scored in the F2 generation, and others turned out to have
multiple integrations which were separated during breeding, we
ultimately analyzed expression in 206 lines. Larval expression pat-
tern frequencies were compared using Chi-squared analysis; for
post-hoc, a Tukey-type contingency test for multiple comparisons
was used [q(0.05,∞, 4) = 3.63] (Zar, 1996). Significant results are
reported by P < 0.05 and q(0.05,∞,4) > 3.63. SPSS and Gnumeric
were used for statistical analysis.
RESULTS
NRSE MOTIFS SUPPRESS NON-NEURONAL EXPRESSION IN
TRANSIENT TRANSGENICS
We scanned the zebrafish genome with the core NRSE consen-
sus motif TCAGCACCnnGGACAG (Bruce et al., 2004; Mortazavi
et al., 2006), accepting one mismatch (Figure 1A). This identi-
fied 1102 potential NRSE sites, similar to the previously reported
FIGURE 1 | Identification of NRSE sites for testing with basal
promoters. (A) Sequence logo representing the consensus zebrafish
NRSE sequence. Base positions are relative to the core 16bp element
(black). Stack height at each position indicates the degree of conservation
and letter height shows relative frequency. (B) Zebrafish NRSE sequences
ranked by the number of instances where they are less than 500 bp from
the transcription start site (Count <500 bp). Also shown for each: the total
number of instances of each sequence in the genome, the minimum
interval from a sequence to its neighboring NRSE and whether evidence
has been reported for rest binding [taken from (Bruce et al., 2004), n/d, not
determined]. The ATG in the second NRSE is underlined. (C) Schematic
of the constructs tested, in order: SCP1:Gal4ff, REx2-SCP1:Gal4ff,
hsp70:Gal4ff, REx2-hsp70:Gal4ff, cFos:Gal4ff, REx2-cFos:Gal4ff. The DNA
sequence of the REx2 element, containing the third (green) and first (red)
NRSE sequences from (B) is expanded. Elements are shown to scale,
except that only part of the tol2 arms at either end of the construct are
represented (broken brown arrows).
number of sites in zebrafish (Mortazavi et al., 2006), compris-
ing 242 different sequences. As we intended to test NRSE sites
by placing multiple elements upstream of a small core promoter,
we ranked the 242 putative NRSE elements by the number of
times they were found within 500 bp of a transcriptional start site
and determined the minimum distance to the nearest neighbor
NRSE (Figure 1B). Three of the top ranked elements were perfect
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matches to the consensus and occurred at least once within 30 bp
of another NRSE element. These elements had all been previously
demonstrated to bind Rest (Bruce et al., 2004) and were adjacent
to genes known to be brain specific. All three were previously
identified as among the most common NRSE elements in Fugu
rubripes (Bruce et al., 2004). The second ranked sequence con-
tains an ATG codon in a strong Kozak context (accATGg) which
could give rise to spurious transcription in a transgene. We there-
fore tested the efficacy of the 1st and 3rd ranked NRSE motifs
in suppressing non-neuronal expression in zebrafish. Evidence
suggests that variants of the NRSE motif have different affini-
ties for Rest and facilitate repression in different tissues (Bruce
et al., 2004). We performed transient expression experiments,
injecting Tg(UAS:Kaede)s1999t embryos (Davison et al., 2007)
with DNA constructs in which a basal super core 1 (SCP1)
promoter and Gal4ff reporter (Asakawa et al., 2008) were cou-
pled to one of three different NRSE containing motifs: a single
common NRSE element (REx1), two different NRSEs separated
by a 27 bp spacer (REx2), and tandem copies of the REx2 ele-
ment (REx4). NRSE motifs were placed immediately upstream
of the promoter (Figure 1C). The SCP1 promoter had not been
previously used in zebrafish, but was chosen because it com-
bines strong versions of basal promoter elements to give very
high level expression in mammalian cell culture (Juven-Gershon
et al., 2006). Consistent with this, embryos injected with the
SCP1:Gal4ff construct did not show expression only in brain (n =
0/114 injected embryos). In contrast, brain specific expression
was observed in at least 10% of embryos injected with each of the
three NRSE containing constructs [X2
(df = 3) = 35.3, p < 0.001]
(Figure 2A).
The REx2 containing construct yielded the highest pro-
portion of embryos in which only neuronal expression was
observed (26.4%; REx2-SCP1 compared to SCP1, q = 12.76,
p < 0.001) (Figure 2A). The REx4 element more strongly sup-
pressed expression in skin and notochord but also suppressed
expression in brain [X2
(df = 3) = 79.70, p < 0.001; percentage
with brain in REx4-SCP1 compared to SCP1, q = 14.93, p <
0.001] (Figure 2B). Examination of expression in tissues known
to produce severe morphological ablation phenotypes showed
that the REx2 element strongly suppressed expression in heart
[X2
(df = 3) = 39.35, p < 0.001; REx2-SCP1 compared to SCP1,
q = 9.44, p < 0.001], notochord [X2
(df = 3) = 67.98, p < 0.001;
q = 10.66, p < 0.001], skin [X2
(df = 3) = 89.83, p < 0.001; q =
13.59, p < 0.001] and muscle [X2
(df = 3) = 78.51, p < 0.001;
q = 15.44, p < 0.001].
To confirm the efficacy of the REx2 element, we tested whether
it could also suppress non-neuronal expression by the hsp70 pro-
moter, which has previously been used for enhancer trapping
in zebrafish (Feng et al., 2007; Scott et al., 2007). We inserted
the REx2 element at the 5′ end of the promoter, in this case
767 bp from the translational start site (Figure 1C). The REx2
element increased brain-specific expression 11.2-fold [X2
(df = 1) =
8.81, p < 0.005] (Figure 2C), suppressing expression in heart
[X2
(df = 1) = 46.07, p < 0.001] and skin [X2(df = 1) = 14.72, p <
0.001], but not in muscle [X2
(df = 1) = 0.49, 0.75 > p > 0.50] or
brain [X2
(df = 1) = 0.38, 0.75 > p > 0.50] (Figure 2D). Ectopic
expression is commonly seen in transient transgenic assays. The
reduction in non-neuronal expression with constructs including
the REx2 element was therefore encouraging, but to definitively
show its effectiveness we next sought to show that it suppresses
expression outside the nervous system in stable transgenic
lines.
EFFICACY OF REx2 ELEMENT FOR ENHANCING TRAPPING
To characterize whether the REx2 element also increased the
recovery of brain specific enhancer trap lines, we performed two
enhancer trap screens, comparing recovery of brain specific Gal4ff
reporter transgenic lines with, and without the REx2 element
(Figure 1C). For the first screen we used the cFos promoter, a
well-characterized basal promoter which is silent in the absence of
transcriptional activating enhancer elements (Fisher et al., 2006)
and which has previously been used in a zebrafish enhancer
trap (Scott and Baier, 2009). To visualize expression patterns
we maintained all lines with Tg(UAS:Kaede)s1999t. Since most
founder fish contained multiple transgene integrations resulting
in overlapping reporter expression patterns (average 3.6), we bred
each through multiple generations to isolate transgenic lines with
unique expression patterns that segregated close to Mendelian
ratios. For each enhancer trap construct we kept the first 50
lines showing any reporter expression irrespective of the pattern
of expression in order to quantitatively compare the effective-
ness of the REx2 element. We examined larvae at 1 dpf and 4 dpf
for expression in brain, heart, muscle, or notochord. As in pre-
vious enhancer traps, almost all lines recovered showed some
degree of expression in the brain. Lines that were made using the
REx2 containing vector showed a marked reduction in expression
outside the nervous system [X2
(df = 1) = 23.89, p < 0.001], that
was highly significant for muscle [X2
(df = 1) = 30.96, p < 0.001]
(Figure 3A). Recovery of brain specific lines increased 4.3-fold
at 1 dpf (q = 10.64, p < 0.05) and 4.9-fold at 4 dpf (q = 9.86,
p < 0.05) (Figure 3C).
For the second enhancer trap screen, we used the SCP1 pro-
moter, speculating that although it is sufficient to drive strong
expression alone, it might nevertheless be susceptible to reg-
ulation by genomic enhancers and silencers of transcription.
Consistent with its strong basal promoter activity, the SCP1 pro-
moter tended to show a higher level of activity in non-neuronal
tissues than the cFos promoter in stable transgenics [X2
(df = 3) =
8.38, p < 0.05]. Again, lines containing the REx2 element had
significantly reduced expression outside the nervous system
[heart, X2
(df = 1) = 12.68, p < 0.001, muscle, X2(df = 1) = 17.99,
p < 0.001, notochord, X2
(df = 1) = 14.41, p < 0.001] (Figure 3B)
such that recovery of brain specific lines increased 2.0-fold at 1 dpf
(q = 4.69, p < 0.05) and 5.4-fold at 4 dpf (q = 6.92, p < 0.05)
(Figure 3C).
Improvements in the proportion of brain specific lines would
not be experimentally useful unless the lines recovered marked
neuroanatomically distinct structures. For lines with any expres-
sion in the brain we classified 4 dpf neuronal expression patterns
as “stochastic” (scattered asymmetric expression in the brain,
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FIGURE 2 | Testing NRSE derived DNA elements for suppression of
non-neuronal reporter expression. (A,B) Transient expression of Gal4ff
reporter constructs with different combinations of NRSE elements (green and
red boxes) at the 5′ end of a SCP1 basal promoter. (A) Percentage of 48 hpf
embryos where cells expressing the reporter were observed only in the
nervous system. The number of embryos examined for each construct is
indicated. Letters show post-hoc Tukey tests, p < 0.05 where letters differ.
(B) Percentage of embryos with any cells observed in the indicated tissues
after injection with SCP1:Gal4 (blue), REx1-SCP1:Gal4 (green), REx2-SCP1
(black) and REx4-SCP1 (gray) plasmids. N is for the cognate construct in (A).
Letters show post-hoc tests for multiple proportions for each tissue type,
p < 0.05 where letters differ. (C) and (D) Transient expression of hsp70:Gal4ff
(white bars) and REx2-hsp70:Gal4ff (black bars) plasmids. (C) Percentage of
embryos with reporter expression only in brain or spinal cord and number of
embryos examined for each construct. ∗p < 0.005. (D) Percentage of
embryos with any expression in the indicated tissues. ∗p < 0.001.
varying between larvae in a clutch), “discrete” (reproducibly
marking the same set of neuroanatomical structures) or “broad”
(showing uniform expression throughout the brain) (Figure 3D).
For the cFos promoter, inclusion of the REx2 element did not sig-
nificantly alter the proportion of lines categorized as stochastic,
discrete or broad [X2
(df = 3) = 6.14, 0.25 > p > 0.1] (Figure 3E).
However, lines recovered from the REx2-SCP1 enhancer trap
showed a small increase in the proportion of lines with neu-
roanatomically discrete expression patterns [X2
(df = 1) = 4.43,
p < 0.05] (Figure 3F).
In both the REx2-cFos and REx2-SCP1 enhancer traps, 80%
of lines recovered labeled a discrete population of cells in the
nervous system. This would be misleading if the REx2 motif
simply lead to repeated recovery of lines with a particular expres-
sion pattern. We scored four easily recognized neuronal cell
groups and calculated the proportion of the discrete lines in
which any of those groups were labeled (Figures 3G,H). Inclusion
of the REx2 element did not significantly alter the recovery
of lines with bias in a particular expression pattern for either
cFos [X2
(df = 3) = 1.45, 0.75 > p > 0.5] or SCP1 [X2(df = 3) = 5.0,
0.25 > p > 0.1]. As a final metric, we scored lines which had
specific brain expression in a very restricted pattern, labeling
only a small group of nuclei or cluster of cells (see for exam-
ple Et(REx2-cFos:Gal4ff)y236 in Figure 4D). Of the 16 lines that
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FIGURE 3 | Recovery of brain specific enhancer trap lines using the
REx2 element. (A) Percentage of enhancer trap lines recovered with
expression in the indicated tissues at 4 dpf, using a cFos:Gal4ff construct
(51 lines, dark bars) and a REx2-cFos:Gal4ff construct (52 lines, light bars).
(B) As for (A), but with enhancer trap constructs SCP1:Gal4ff (52 lines,
dark bars) and REx2-SCP1:Gal4ff (51 lines, light bars). (C) Percentage of
lines with expression only observed in the nervous system at 1 dpf and
4dpf for each of the enhancer trap constructs used. (D) Examples of Gal4
enhancer trap lines with stochastic, discrete and broad expression in the
brain. Lines were crossed to Tg(UAS:Kaede)s1999t for visualizing
expression. (E) and (F) show the percentage of lines with expression in
discrete brain structures (checks), broad expression through the brain (gray)
or stochastic asymmetric expression in the brain (white) for the indicated
enhancer trap constructs. (G) Percentage of lines with expression in the
indicated neuronal cell types at 4 dpf for enhancer trap lines generated
using the cFos:Gal4ff (dark bars) and REx2-cFos:Gal4ff (light bars)
constructs. (H) As for (G) but with SCP1:Gal4ff (dark bars) and
REx2-SCP1:Gal4ff (light bars). ∗p < 0.001 for all panels.
met this stringent standard, 15 were made using a construct con-
taining the REx2 element [cFos,X2
(df = 1) = 5.53, p < 0.05; SCP1,
X2
(df = 1) = 7.66, p < 0.01]. Together, these assessments demon-
strate that the REx2 element leads to a substantial improvement in
the recovery of enhancer traps which cleanly label specific groups
of cells in the brain. Such lines are the most useful for map-
ping brain circuitry because they permit manipulations of small
populations of cells within the brain.
REx2 ELEMENT SUPPRESS NON-NEURONAL EXPRESSION
THROUGH REST
To test our working hypothesis that the REx2 element improves
brain specific enhancer trapping by selectively suppressing non-
neuronal expression of the transgene, we injected a morpholino
against rest mRNA into lines which showed little or no expression
outside the brain, reasoning that this should expand the pattern
of reporter expression into transgenic lines where the REx2 ele-
ment normally suppresses non-neuronal expression. We used a
previously described splice-blocking morpholino which allows
near normal embryonic development through 72 hpf (Gates et al.,
2010). Using qPCR, we confirmed that as reported, at 5 ng per
embryo, knockdown is robust through 24 hpf with an 85.5%
reduction in rest expression (t-test, p < 0.001). Injection of the
rest morpholino into cFos:Gal4 enhancer trap lines (lacking the
REx2 element) revealed no changes in expression at days 1–3
when rest knockdown embryos show only minor morphological
abnormalities (n = 5 lines). When injected into REx2-cFos:Gal4
lines, we saw changes in expression consistent with de-repression
of the reporter in non-neuronal tissues in 3 of 10 lines injected.
In Et(REx2-cFos:Gal4ff)y236;Tg(UAS:Kaede)s1999t embryos,
we saw Kaede expression in the hatching gland at 24 hpf in mor-
phants (n = 22/27), but not in embryos injected with control
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FIGURE 4 | Knockdown of rest reveals non-neuronal expression in
REx2 enhancer trap lines. In (A,C,E) confocal stacks show 2dpf
embryos immunostained with anti-Kaede (green), counterstained with
Hoechst (blue). (B,D,F) are live confocal stacks of Kaede expression in
4 dpf embryos with the outline of the head (solid line) and brain (dotted
line). (A) Et(REx2-cFos:Gal4ff)y236;Tg(UAS:Kaede)s1999t embryos injected
with (i) control morpholino or (ii) morpholino targeting rest. Arrowheads
show heart cells. (B) At 4 dpf y236 larvae show reporter expression
in hypothalamus (asterisk) and the Mauthner cells (arrowhead). (C)
Et(REx2-cFos:Gal4ff)y237;Tg(UAS:Kaede)s1999t embryos injected with (i)
control morpholino or (ii) morpholino targeting rest. Arrowheads show
cranial vasculature. (D) At 4 dpf y237 larvae show reporter expression in
the optic tectum (arrowhead) and caudal hindbrain (asterisk). (E)
Et(REx2-cFos:Gal4ff)y238;Tg(UAS:Kaede)s1999t embryos injected with (i)
control morpholino or (ii) morpholino targeting rest. Arrowheads show
heart cells. (F) At 4 dpf y238 larvae show reporter expression in the
optic tectum (asterisk) and a medially located population of cells in the
hindbrain (arrowhead). (G,H,I) are single 2µm confocal slices for 3 dpf
embryos co-stained for Kaede expression (green) and the neuronal
marker elav1 (red), centered on the regions marked with the arrowheads
in (B,D,F) respectively. Scale bars: (A,C,E) 40µm, (B,D,F) 100µm, (G,H,I)
50µm.
morpholino [n = 0/28; X2
(df = 1) = 39.6, p < 0.001]. By 30 hpf,
morphants showed expression in the heart, which strength-
ened through 48 hpf while control injected embryos showed
little or no heart expression [number of heart cells expressing
reporter: control 1.7 ± 0.8, morphants 5.0 ± 1.1, t-test t(9.1) =
2.5, p = 0.036, N = 6 embryos each] (Figure 4A). By 4 dpf,
y236 larvae show strong expression in the hypothalamus, weaker
expression in the olfactory bulb and only stochastic labeling of
cells outside the brain (Figure 4B). In a second line, Et(REx2-
cFos:Gal4ff)y237; Tg(UAS:Kaede)s1999t, uninjected and control
morpholino injected embryos show only brain expression at
the caudal edge of the otic vesicle at 30 hpf, with weak varie-
gated expression of Kaede in intersegmental vessels in a minority
of embryos at 48 hpf (n = 5/25). Injection of the rest mor-
pholino into this line strengthened expression in trunk interseg-
mental vessels (n = 25/30) with additional cranial vasculature
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expression not seen in controls at 48 hpf (Figure 4C). From 48 hpf
through 4 dpf, y237 embryos mark a small population of neu-
rons in the optic tectum and caudal hindbrain (Figure 4D).
Et(REx2-cFos:Gal4ff)y238; Tg(UAS:Kaede)s1999t embryos have
strong expression in the forebrain, ventral retina, pronephric
ducts and caudal tail fin at 24 hpf. At 48 hpf, there is also
weak expression in the heart. Injection of the rest mor-
pholino led to a robust increase in heart expression [number
of heart cells expressing reporter: control 3.2 ± 1.1, morphants
10.0 ± 2.2, t-test t(6.3) = 2.7, p = 0.034, N = 5 embryos each]
(Figure 4E). By 4 dpf, y238 larvae have additional expres-
sion in the optic tectum, hindbrain and trunk neuromasts
(Figure 4F).
We asked whether the expanded expression patterns seen with
rest morpholino injection specifically reflects recovery of the
normal non-neuronal pattern of expression of genes adjacent
to the integration site whose enhancers are driving expression
of the reporter. We were able to map the integration site for
two lines. Et(REx2-cFos:Gal4ff)y238 integrated at chr3:10432994.
Since the nearest annotated genes, rnps1 and cbx2 both show
broad patterns of expression (Thisse and Thisse, 2004), it is
possible that the heart expression after rest morpholino injec-
tion reflects recovery of the non-neuronal expression domain
of one of these genes. Et(REx2-cFos:Gal4ff)y237 mapped to
chr25:19691130 (zv9), within the promoter region of hyaluronan
and proteoglycan link protein 3 (hapln3), 190 bp from the start
of transcription (Figure 5A). Reporter expression in the brain of
y237 transgenic larvae resembles that of hapln3 with both show-
ing expression in the optic tectum and adjacent to the otic vesicle
(Figures 5B,C). Transgenic larvae show an additional locus of
expression in the hindbrain not detected by in situ hybridiza-
tion for hapln3. However, hapln3 is expressed in several areas
outside the nervous system, including in the hatching gland,
pectoral fin, median fin fold, and vasculature, including cranial
and trunk vasculature (Thisse and Thisse, 2004) (Figures 5C–F).
This pattern of non-neuronal expression is not observed in y237
larvae, which could be due to either incomplete regulatory con-
trol of the transgene, or due to the REx2 motif suppressing
non-neuronal expression. The vasculature expression domain is
partially restored in rest morphant y237 larvae, suggesting that
that the REx2 element suppresses non-neuronal expression of
the reporter that would normally be driven by local genomic
enhancers.
DISCUSSION
Here we define a short DNA fragment containing two NRSE
sequences that suppresses expression outside the nervous system.
Guided by a ChIP analysis that showed greatest occupancy of
NRSE sites in genes containing two different sites within 30 bp
of each other (Bruce et al., 2004), we designed the REx2 ele-
ment using zebrafish NRSE elements that (1) appear within 500
bases of a transcriptional start site, (2) are situated within 30 bp
of another NRSE element and (3) were previously shown to bind
Rest. Our data provides quantitative evidence that when included
in an enhancer trap vector, this element strongly enriches the
recovery of transgenic lines with expression limited to the nervous
system. REx2 transgenics robustly label diverse neuronal subtypes
FIGURE 5 | REx2 enhancer trap y237 recapitulates tectal expression of
the adjacent hapln3 gene. (A) The Gal4ff reporter in y237 is integrated on
chromosome 3, between mfge8b and hapln3, 190 bp from the first exon of
hapln3. (B) y237 transgenic larvae show Kaede reporter expression in the
optic tectum (arrowhead), adjacent to the otic vesicle (asterisk) and in the
hindbrain (bracket). Lateral view, 2 dpf. (C) WISH (2 dpf) shows that hapln3
is expressed in the optic tectum (arrowhead), in the otic vesicle (asterisk)
and non-neuronal tissues including pectoral fin (bracket). (D) Dorsal view of
head (2 dpf) reveals cranial vasculature expression of hapln3, arrowhead
shows basal communicating artery (Isogai et al., 2001). (E) Lateral view of
tail (30 hpf) shows expression of hapln3 in the dorsal aorta (bracket), the
source of cells which form intersegmental vessels (arrowhead). (F) Lateral
view of yolk (28 hpf) showing hapln3 in hatching gland (arrowhead).
and yield high quality expression patterns. This method is thus a
simple and effective way to restrict transgene expression to the
nervous system.
We considered alternative strategies for confining enhancer
trap expression to the brain. Based on our transient transgenic
data, we expected that the REx2 element would also suppress
expression of a reporter gene from a UAS-E1b promoter. This was
not the case, nor were we able to suppress expression from the
UAS-E1b promoter when the REx2 motif was placed in an intron
downstream of this promoter (data not shown). Previous work
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has shown that Gal4 can reactivate silenced UAS-E1b transgenic
reporters (Goll et al., 2009) and it is possible that Gal4 simi-
larly reverses Rest mediated transcriptional silencing. However, as
many zebrafish Gal4 lines with expression both in the brain and
non-neuronal tissues exist, we are continuing work to extend this
technique to enable suppression of non-neuronal expression from
UAS reporter lines.
An intersectional method could also be used to restrict
enhancer trap expression to the nervous system, for instance by
breeding Gal4 lines with double transgenic HuC:Cre; UAS:lox-
STOP-lox-nfsB-mCherry fish. In this case, brain specific expres-
sion of Cre by the HuC promoter (Park et al., 2000) would
ensure that Gal4 only activates NTR-mCherry expression in the
nervous system. Intersectional strategies have proven highly suc-
cessful in Drosophila, and are feasible in zebrafish (Faucherre and
Lopez-Schier, 2011; Fujimoto et al., 2011). We did not pursue
this approach because of the additional generation of breeding
required to obtain triple transgenic fish and the low proportion
of triple transgenic embryos expected from crosses. Both fac-
tors would tend to reduce the throughput of a large scale circuit
breaking screen.
The REx2 element suppressed non-neuronal expression not
only from the short cFos and SCP1 basal promoters, but also
reduced expression in heart and skin when upstream of a 640 bp
fragment of the hsp70 promoter. It may therefore also aid in refin-
ing expression to the nervous system in transgenic lines using
defined promoter elements. As the element was not effective with
the UAS-E1b promoter and did not suppress muscle expression
from the hsp70 promoter, efficacy is likely to vary with differ-
ent promoters. We note that in mammals, Rest is expressed in
immature neurons (Ballas et al., 2005) and at low levels in adult
hippocampal neurons (Sun et al., 2005). Although the region
homologous to hippocampus is small or absent in zebrafish lar-
vae, rest is expressed prior to neuronal differentiation in the
zebrafish CNS (Gates et al., 2010; Wang et al., 2012) and it will
therefore be interesting to see whether transgenic lines made with
the REx2 motif show reduced expression in neuronal precur-
sor cells. We recognized distinctive mature neuronal cell types in
REx2 containing enhancer trap lines including retinal ganglion
cells, trigeminal sensory neurons, motor neurons, and reticu-
lospinal neurons. Moreover co-staining for the neuronal marker
elav1 confirmed that many cells in y236, y237, and y238 enhancer
trap lines are neurons (Figures 4G–I). Thus, the REx2 enhancer
trap lines do indeed label neurons.
By morpholino knockdown of rest mRNA, we saw increased
expression of REx2 containing transgenes in non-neuronal
tissues. Our data is therefore consistent with the REx2 ele-
ment suppressing expression that would normally be activated by
enhancer elements which direct expression outside the nervous
system. Previously it has been demonstrated that anNRSE confers
brain specific expression in transgenic Xenopus (Tan et al., 2010)
and in zebrafish, a recent report has shown de-repression of non-
neuronal reporter expression in NRSE containing enhancer trap
lines in a rest mutant background (Kok et al., 2012). The partial
recovery of non-neuronal expression patterns in rest morphant
transgenic larvae likely reflects incomplete morpholino knock-
down of rest transcript and non-neuronal expression is expected
to be more extensive in the rest mutant background (Kok et al.,
2012).
Existing enhancer trap reporter lines show significant levels of
expression outside the nervous system. These lines have proven
invaluable for functional neuroanatomical studies where reporter
function can be experimentally triggered or monitored in a local-
ized manner (Del Bene et al., 2010; Lee et al., 2010; Schoonheim
et al., 2010) however, morphological defects after cell death in
non-neuronal tissues make most of these lines unsuitable for
an ablation based circuit breaking screen. Our preliminary data
from ablating cells in Gal4 enhancer trap lines using a UAS:NfsB-
mCherry reporter indicates that around half of the SCP1 lines
tested die or show severe morphological defects after ablation,
while only 10% of the REx2-SCP1 lines have similar phenotypes.
Transgenic lines in which reporter expression is confined to
the nervous system are also essential for other circuit analysis
techniques, particularly in unrestrained animals where reporter
function needs to be localized genetically. Channelrhodopsin2
(ChR2) can be used for controlling neuronal activity in freely
swimming zebrafish (Zhu et al., 2009), but ChR2 is also a robust
modulator of muscle cell contraction (Arrenberg et al., 2010).
Tracking neuronal activity in free swimming larvae using bio-
luminescent calcium imaging is a powerful method (Naumann
et al., 2010), butwith the confound that muscle calcium transients
are large and likely to swamp signals from neurons during swim
bouts (Cheung et al., 2011). The advance we report here will thus
enhance the application of powerful circuit mapping techniques
for analyzing the neuronal basis of behavior in zebrafish.
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